On May 17, Axinn partner Chad Landmon will moderate the "Director’s Update: Center for Biologics Evaluation and Research (CBER)" panel at the Food and Drug Law Institute's Annual Conference, being held May 17-18 in Washington, DC and virtually.

During the panel, FDA leadership will address the top issues CBER is facing as well as priorities and goals for the upcoming year. 

Click here for more information, including how to register.